Advanced Adjuvants for Novel Vaccines: Expanding Access to Technology in the Fight Against Infectious Disease
This fact sheet describes the positive impact that adjuvants can have on vaccine efficacy and, potentially, immunization program costs. It also describes PATH’s work to expand global access to proprietary and non-proprietary adjuvants as well as relevant formulations technologies to facilitate their successful exploration and use by product development partnerships and developing-country vaccine manufacturers.
» Download file (English)
709 KB PDF (Located at www.path.org)
Diseases/vaccines: Not disease/vaccine specific